Skip to main content
. 2017 Jun 27;13:739–750. doi: 10.2147/TCRM.S134039

Table 1.

Baseline characteristics

Characteristics of patients SG (n=50) CG (n=50) SCG (n=50) PG (n=50) P-value
Age (years) 69.1±8.4 67.8±7.5 68.9±8.8 68.5±8.0 0.246
Gender, male, n (%) 29 (58) 31 (62) 30 (60) 32 (64) 0.683
Race, n (%)
 Han zhu 44 (88) 43 (86) 44 (88) 43 (86) 0.766
 Manchu 4 (8) 5 (10) 4 (8) 5 (10) 0.727
 Mongolians 1 (2) 1 (2) 1 (2) 1 (2) 1.000
 Tibetans 1 (2) 1 (2) 1 (2) 1 (2) 1.000
Weight (kg) 85.6±16.4 84.7±14.6 86.7±15.8 86.1±15.0 0.145
BMI (kg/m2) 28.2±2.9 27.8±2.6 28.5±2.7 28.9±2.4 0.532
Hemoglobin A1c (%) 7.6±0.9 7.9±0.9 7.5±0.8 7.6±0.7 0.107
Duration of diabetes (years) 5.8±4.6 5.5±4.2 5.6±4.9 5.7±4.2 0.642
HR (beats/minute)
 24-hour 76.8±14.2 78.4±14.0 77.4±15.1 76.4±14.6 0.728
 Daytime 81.2±12.3 80.2±11.5 80.8±13.5 80.4±12.1 0.859
 Nighttime 69.4±8.6 67.6±9.0 68.9±9.5 66.5±8.4 0.678
SBP (mmHg)
 24-hour 141.7±12.6 130.6±11.2 139.5±11.9 134.5±10.3 0.554
 Daytime 151.4±13.7 153.2±13.2 150.6±12.8 147.6±11.9 0.762
 Nighttime 140.8±14.2 140.5±13.3 142.4±13.6 145.5±11.8 0.331
DBP (mmHg)
 24-hour 85.6±8.2 86.6±7.5 86.0±7.3 86.7±7.1 0.426
 Daytime 87.5±8.0 86.2±7.4 89.1±7.8 85.9±7.2 0.584
 Nighttime 79.4±8.2 77.4±6.9 78.9±6.6 78.0±6.1 0.252
Failing with single-drug treatment, n
 BIA 17 19 17 19 0.677
 Exenatide 15 16 15 16 0.829
 MET 14 13 13 14 0.822

Notes: Chi-square test and t-test were performed to compare the variance between two groups. There are significant statistic differences at P<0.05. Data presented as mean ± SD unless indicated otherwise.

Abbreviations: SCG, sitagliptin and chitosan oligosaccharide group; CG, chitosan oligosaccharide group; SG, sitagliptin group; PG, placebo group; BMI, body mass index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; BIA, biphasic insulin aspart; MET, metformin.